The dilemma of anticoagulant therapy in coronary heart disease
Loeliger, E.A.
Nederlands Tijdschrift Voor Geneeskunde 114(19): 810-813
1970
ISSN/ISBN: 0028-2162 PMID: 5424728 Document Number: 20276
Document emailed within 1 workday
Related Documents
Visser, J. 1970: The dilemma of anticoagulant therapy in coronary heart disease Nederlands Tijdschrift Voor Geneeskunde 114(29): 1221-1223Tayer-Shifman, O.E.; Seyahi, E.; Nowatzky, J.; Ben-Chetrit, E. 2012: Major vessel thrombosis in Behçet's disease: the dilemma of anticoagulant therapy - the approach of rheumatologists from different countries Clinical and Experimental Rheumatology 30(5): 735-740
Kaem, G.R. 1975: Importance of long-term anticoagulant therapy in ischemic heart disease Terapevticheskii Arkhiv 47(10): 124-131
Guliamov, K.G. 1974: Effect of anticoagulant therapy on vascular permeability in patients with ischemic heart disease Terapevticheskii Arkhiv 46(9): 75-80
Baggio, D.; Madore, F.; Lalonde, G. 2000: Oral anticoagulant therapy for heart disease: results in actual cardiology practice Canadian Journal of Cardiology 16(2): 153-161
Arntz, H.R.; Wunderlich, W.; Schnitzer, L.; Stern, R.; Fischer, F.; Agrawal, R.; Linderer, T.; Schultheiss, H.P. 1999: Short- and long-term effects of intensified versus conventional antilipidemic therapy in patients with coronary heart disease. Results from the Lipid-Coronary Artery Disease (L-CAD) Study Zeitschrift für Kardiologie 88(8): 582-590
Belenkov, Y.N.; SHakaryants, G.A.; Khabarova, N.V. 2018: Tactics of Selection of Anticoagulant Therapy in Patients With Atrial Fibrillation and Ischemic Heart Disease Kardiologiia 2018(3): 43-52
Jenni, D.; Osterwalder, R.; Osswald, S.; Buser, P.; Pfisterer, M. 2001: Are we treating coronary heart disease and heart failure appropriately in the clinic and ambulatory care? Secondary prevention and drug therapy 1998 Praxis 90(41): 1759-1765
Niederberger, M. 1976: Therapy of coronary heart disease Wiener Medizinische Wochenschrift 126(32-35): 469-473
Zhdan, V.; Khaymenova, G.; Shilkina, L.; Martynyuk, D.; Babanina, M.; Mamontova, T. 2017: Determine the effectiveness of lipid-lowering therapy in patients with chronic obstructive pulmonary disease combined with coronary heart disease Wiadomosci Lekarskie 70(2 Part 2): 303-305
Rifkind, B.M.; Levy, R.I. 1974: Does hypolipidemic therapy prevent coronary heart disease? Cardiovascular Clinics 6(2): 1-8
Zhu, G. 1996: Problems in interventional therapy of coronary heart disease Zhonghua Nei Ke Za Zhi 35(3): 147-148
Meyer, J. 1983: Use of calcium antagonists in the therapy of coronary heart disease Der Internist 24(7): 408-414
Leschke, M.; Motz, W.; Strauer, B.E. 1986: Hemorheologic therapy applications in coronary heart disease Wiener Medizinische Wochenschrift 136(Special Issue): 17-24
Amano, K. 2003: Coronary heart disease and hormone replacement therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 61(Suppl 5): 914-919
Mehta, J.L. 1982: Platelets and coronary heart disease: therapy update Geriatrics 37(5): 129-34 139
Erbel, R.; Ge, J.; Haude, M.; Görge, G. 1995: Alternative methods in interventional therapy of coronary heart disease Zeitschrift für Kardiologie 84(Suppl 2): 53-64
Bleifeld, W.; Spokojny, A. 1983: Therapy of coronary heart disease with calcium antagonists in clinical practice Die Medizinische Welt 34(47): 1335-1339
Egger, M.; Junghans, C.; Friis Moller, N.; Lundgren, J.D. 2001: Highly active antiretroviral therapy and coronary heart disease: the need for perspective AIDS 15(Suppl 5): S193-S201
Stauch, M.; Schmidt, A.; Kress, P. 1987: Problems in long-term therapy of coronary heart disease: clinical aspects Medizinische Klinik 1: 24-28